REQUEST A DEMO
Total
USD $0.00
Search more companies

Nutopi Sp. z o.o. (Poland)

Main Activities: Medical Equipment and Supplies Manufacturing
Secondary Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Nutopi Sp. z o.o. Profile Updated: November 08, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Nutopi Sp. z o.o is a company that offers outsourcing services for SMEs in the medical industry. They specialize in R&D of new Medical Devices for In Vitro Diagnostic use and small scale manufacturing, with a focus on affordable products for clinics and home testing. The company's team of scientists has extensive knowledge in ELISA, LFI, and Clinical Chemistry techniques. They also offer small scale production for novel tests and assistance in researching and developing medical devices for in-vitro diagnostics.

Headquarters
Ul. Rubiez 46H
Poznan; Wielkopolskie; Postal Code: 61-612

Contact Details: Purchase the Nutopi Sp. z o.o. report to view the information.

Website: http://www.nutopi.com

Basic Information
Total Employees:
Purchase the Nutopi Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Nutopi Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Nutopi Sp. z o.o. report to view the information.
Incorporation Date:
March 10, 2014
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
98%
Company Performance
Financial values in the chart are available after Nutopi Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
10.51%
Total operating revenue
6.95%
Operating profit (EBIT)
-16.22%
EBITDA
-16.49%
Net Profit (Loss) for the Period
-17.81%
Total assets
73.56%
Total equity
35.07%
Operating Profit Margin (ROS)
-6.45%
Net Profit Margin
-6.29%
Return on Equity (ROE)
-16.71%
Quick Ratio
-0.58%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?